SCHEMBL14729256

SCHEMBL14729256

CC(C)(C)OC(=O)CCNOCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CA12 O43570 2/20 0.42
CA7 P43166 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA1 P00915 1/20 0.42
SYK P43405 1/20 0.41
PPARA Q07869 1/20 0.41
IDO1 P14902 1/20 0.40
AKT1 P31749 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LTA4H P09960 1/20 0.40
CA9 Q16790 1/20 0.40
MAPT P10636 1/20 0.39
CTSS P25774 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4422666 0.85 NPC1 (0.45) NPC1RAB9ACA12CA7CA14
SCHEMBL10824461 0.84 ALDH1A1 (0.54) NPC1RAB9ACA12CA7CA14
SCHEMBL20094984 0.81 ALDH1A1 (0.49) SYKIDO1ALDH1A1LTA4HMAPT
SCHEMBL19853352 0.81 IDO1 (0.54) CA12CA7CA14CA1SYK
SCHEMBL18241200 0.81 LTA4H (0.51) NPC1RAB9AALDH1A1LTA4H
SCHEMBL6049741 0.80 HTT (0.59) SYKIDO1MAPT
SCHEMBL9157683 0.80 ALDH1A1 (0.52) NPC1RAB9AALDH1A1
SCHEMBL9543244 0.79 HTT (0.53) NPC1RAB9AALDH1A1LTA4HHDAC3
SCHEMBL25278008 0.79 LTA4H (0.48) CA12CA7CA14CA1SYK
SCHEMBL557536 0.79 ALDH1A1 (0.46) RAB9ACA1SYKPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583887-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2026-03-24 US disclosed
US-12559521-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2026-02-24 US disclosed
EP-4678240-A2 BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES Hangzhou Dac Biotech Co., Ltd. (CN) 2026-01-14 EP disclosed
EP-3319936-B1 BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES HANGZHOU DAC BIOTECH CO LTD (CN) 2025-12-17 EP disclosed
US-20240425547-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2024-12-26 US disclosed
US-20240409580-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2024-12-12 US disclosed
US-12139554-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2024-11-12 US disclosed
US-12122851-B2 PSMA imaging agents SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2024-10-22 US disclosed
US-20230001001-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-01-05 US disclosed
US-20230001001-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-01-05 US disclosed
US-20170209595-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-07-27 US disclosed
US-20170209595-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-07-27 US disclosed
US-20170202975-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-07-20 US disclosed
US-20170202975-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-07-20 US disclosed
US-20170151346-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-06-01 US disclosed
US-20170151346-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD. (CN) 2017-06-01 US disclosed
US-20160304555-A1 PSMA Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2016-10-20 US disclosed
US-20150314017-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD (CN) 2015-11-05 US disclosed
US-20150314017-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE SUZHOU M-CONJ BIOTECH CO., LTD (CN) 2015-11-05 US disclosed
WO-2013028664-A1 PSMA IMAGING AGENTS SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425547-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 NPC1 661/4885RAB9A 1005/4885CA12 40/4885
US-20170151346-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM NPC1 4492/4885RAB9A 3489/4885CA12 72/4885
US-20230001001-A1 CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE CD4, MCL1, CCNB1 NPC1 1637/4885RAB9A 1610/4885CA12 716/4885
US-20240409580-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 NPC1 661/4885RAB9A 1005/4885CA12 40/4885
US-20170209595-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM NPC1 4492/4885RAB9A 3489/4885CA12 72/4885
US-12559521-B2 PSMA imaging agents KLK3, PSMA1, PSMA6 NPC1 101/4885RAB9A 1350/4885CA12 20/4885
US-12139554-B2 PSMA imaging agents FOLH1, KLK3, PSMA2 NPC1 661/4885RAB9A 1005/4885CA12 40/4885
US-12583887-B2 PSMA imaging agents KLK3, PSMA3, PSMA1 NPC1 51/4885RAB9A 1733/4885CA12 19/4885
US-20170202975-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM NPC1 4492/4885RAB9A 3489/4885CA12 72/4885
US-12122851-B2 PSMA imaging agents FOLH1, KLK3, PSMA2 NPC1 661/4885RAB9A 1005/4885CA12 40/4885
US-20150314017-A1 DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE CD74, CD2, EPCAM NPC1 4492/4885RAB9A 3489/4885CA12 72/4885
US-20160304555-A1 PSMA Imaging Agents FOLH1, KLK3, PSMA2 NPC1 661/4885RAB9A 1005/4885CA12 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.